NovelStem International NSTM
OTC NSTM
$0.01 +0.00 (+0.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

NovelStem International (NSTM) Non-Current Deffered Revenue (2010 - 2013)

Updated

NovelStem International's Non-Current Deffered Revenue was $9,000 in Q3 2021, unchanged from the prior quarter.

Analysis

NovelStem International (NSTM) Non-Current Deffered Revenue (2010 - 2013) Analysis & Trends

At the end of FY2012, Non-Current Deffered Revenue at NovelStem International came in at $14,000, down 69.7% from FY2011.

  • In earlier years, Non-Current Deffered Revenue was $46,200 in FY2011 (-68.8%) and $148,002 in FY2010.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 NovelStem International 493,324.54 346,279.54 - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 9,000.00
Jun 30, 2013 9,000.00
Mar 31, 2013 9,000.00
Dec 31, 2012 14,000.00
Sep 30, 2012 35,975.00
Jun 30, 2012 25,475.00
Mar 31, 2012 21,622.00
Dec 31, 2011 46,200.00
Sep 30, 2011 50,101.00
Jun 30, 2011 100,071.00
Dec 31, 2010 148,002.00
API Access

NovelStem International Non-Current Deffered Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-deffered-revenue&ticker=NSTM&period=max&api_key=YOUR_API_KEY